CIEN insider Form 4: 734 shares sold at $169.36; 40,529 held

Rhea-AI Filing Summary

Ciena (CIEN) reported insider activity by its SVP Global R&D. On 10/15/2025, the officer executed two open‑market sales of common stock totaling 734 shares (367 + 367) at a price of $169.36 per share, made pursuant to a Rule 10b5‑1 trading plan dated 9/11/2024. Following these transactions, the officer reported 40,529 shares beneficially owned. The filing notes that the reported holdings include unvested RSUs and PSUs.

Insider Trade Summary

Net Seller: 734 shares ($124,310)

Net Sell 2 txns

Insider DiPerna Dino

Role SVP Global R&D

Sold 734 shs ($124K)

Type	Security	Shares	Price	Value
Sale	Common Stock	367	$169.36	$62K
Sale	Common Stock	367	$169.36	$62K

Holdings After Transaction: Common Stock — 40,896 shares (Direct)

Footnotes (1)

1. Sales were effected pursuant to Rule 10b5-1 trading plan dated 9/11/2024. Shares reported include unvested Restricted Stock Units (RSUs) and Performance Stock Units (PSUs).

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DiPerna Dino

(Last) (First) (Middle)

C/O CIENA CORPORATION

7035 RIDGE RD.

(Street)

HANOVER MD 21076-1426

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CIENA CORP [ CIEN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP Global R&D

3. Date of Earliest Transaction (Month/Day/Year)
10/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/15/2025		S		367(1)	D	$169.36	40,896(2)	D
Common Stock	10/15/2025		S		367(1)	D	$169.36	40,529(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Sales were effected pursuant to Rule 10b5-1 trading plan dated 9/11/2024.

2. Shares reported include unvested Restricted Stock Units (RSUs) and Performance Stock Units (PSUs).

	By: Michelle Rankin For: Dino Diperna	10/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did CIEN report on Form 4?

An officer executed two sales of common stock totaling 734 shares (367 + 367) at $169.36 per share on 10/15/2025.

Who is the reporting person in Ciena (CIEN)'s Form 4?

A company officer serving as SVP Global R&D.

Was the CIEN insider sale under a 10b5‑1 plan?

Yes. The sales were effected under a Rule 10b5‑1 trading plan dated 9/11/2024.

How many CIEN shares does the insider beneficially own after the sale?

The officer reported 40,529 shares beneficially owned after the transactions.

What was the sale price for the CIEN shares?

Each transaction reported a sale price of $169.36 per share.

Do the reported holdings include unvested equity awards?

Yes. The filing notes holdings include unvested RSUs and PSUs.